NEW YORK, Dec. 15, 2011 /PRNewswire/ -- TheraBiogen, Inc. (OTC BB: TRAB), a manufacturer and distributor of homeopathic nasal sprays for aiding in the relief of allergies, cold and flu symptoms and migraine headaches, announced today the launch of its television ad campaign to promote TheraMax® Cold and Flu.
The 30-second TheraMax® Cold & Flu commercial will begin airing on Friday, December 16, 2011 and will continue to air through the first quarter of 2012, at which time the Company will begin a second round of commercials. The commercial will be featured on the Oprah Winfrey Network (OWN), the Food Network, Women’s Entertainment (WE), The Weather Channel, the Lifetime Network and Lifetime Movie Channel. These networks are seen in as many as 90 million homes.
Kelly Hickel, CEO of TheraBiogen, commented, “We are happy to get our commercial in front of hundreds of thousands of television viewers to build awareness of the benefits of TheraMax® Cold and Flu Relief.”
The TheraMax Cold and Flu commercial may be viewed at www.theramaxrelief.com and on the Company YouTube page at http://www.youtube.com/watch?v=JOvnTNaaa_s
TheraMax® Cold and Flu is an all-natural, non-zinc, non-addictive, over-the-counter cold and flu relief agent. Over 50 million Americans contract the flu each year and consumer demand for a homeopathic, non-zinc remedy is a 2.5 billion dollar market according to research studies.
TheraMax® is available for purchase in over twelve thousand locations including Rite-Aid, Food Lion, Hannaford Supermarkets, Discount Drug Marts and Big Y Supermarkets as well as two of the three largest retailers. For more information on TheraMax® visit our website at www.theramaxrelief.com, our Facebook page at facebook.com/theramaxnasalspray or follow us on Twitter at http://twitter.com/TheraMaxRelief.
About TheraBiogen, Inc.
TheraBiogen is a manufacturer and distributor of homeopathic nasal sprays for aiding in the relief of allergies, cold and flu symptoms and migraine headaches. The products are made from natural, homeopathic ingredients and contain no zinc, which has been identified as potentially causing nasal problems in other similar products on the market. For further information please visit www.theramaxrelief.com.
Safe Harbor Statement
This press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21 E of the Securities Exchange Act of 1934, as amended. Investors are cautioned that these forward-looking statements involve uncertainties and risk that could cause actual performance and results of operations to differ materially from those anticipated. These risks are set forth in the Company’s most recently filed form 10-K and Form 10-Q reports. TheraBiogen, Inc. assumes no obligation to update the statements contained in this release except as required by applicable securities laws disclosure rules.
Company Contact: | Public Relations Contact: | Investor Contact: | |
TheraBiogen, Inc. | Megan Megale | Boutcher & Boutcher | |
Kelly T. Hickel, CEO | Megale Public Relations | Aimee Boutcher | |
732-294-8705 | 703-625-8093 | 973-239-2878 | |
Aboutcher@therabiogen.com | |||
SOURCE TheraBiogen, Inc.